Senior insider sale
HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$3.64M
34.23K shares
What this filing means
POSARD MATTHEW L. plans to sell 34.23K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $3.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001950047-26-009587
Director
Since May 2019
34.23K
Shares to sell
$3.64M
Approx. market value
34.23K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/5/2015
34.23KTotal acquired34.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/5/2015 | Restricted Stock Units N/A | 34.23K | — |
| Total | 34.23K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
34.23K
Market value
$3.64M
9/16/2026
Total
Units
34.23K
Value
$3.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/16/2026 | 34.23K | $3.64M | NASDAQ | Planned |
| Total | 34.23K | $3.64M | ||